Health — 30 August 2013

By Richard Lenti

A groundbreaking study using stem cells to treat multiple sclerosis (MS) has been approved by the Food and Drug Administration. If successful, scientists believe it may one day lead to a cure for the autoimmune system disease.

Researchers at the Tisch MS Research Center of New York say that approval of early clinical Phase I trials by the FDA comes after more than a decade of research.

“As important a milestone as the FDA investigational new drug approval is, it marks the true beginning and not the end of our clinical research of stem cell therapy,” wrote Tisch researchers in a statement announcing the trial.

“In this and subsequent studies, we hope to define the optimal therapeutic dose and dosing frequency of stem cells, the best route of administration, whether or not stem cells should be used in combination with other disease modifying treatments, and which patients are most likely to benefit from this treatment.”

Read more at National Pain Report.


About Author

Richard Lenti

Richard Lenti has worked as a news writer for the last 20 years at various television stations in Los Angeles. He is a Golden Mike winner and a graduate of California State University, Fresno. With roots in print journalism, Richard is excited to be “published” once again; having people read his work as opposed to having it read to them. As a freelance writer his work has appeared in the Easy Reader, L.A. Jazz Scene, Irrigation and Green Industry, and the KCAL 9 Online website.

(0) Readers Comments

Comments are closed.